(Q35685409)

English

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo

scientific article published on 16 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Geert Leroux-Roels

11

object named as

Geert Leroux-Roels

0 references

Maria Teresa Catanese

object named as

Maria Teresa Catanese

2

0 references

Philip Meuleman

object named as

Philip Meuleman

1

0 references

Timothy P Sheahan

7

object named as

Timothy Sheahan

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Charles M. Rice

10

object named as

Charles M Rice

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Christopher T Jones

6

object named as

Christopher T Jones

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

3

object named as

Lieven Verhoye

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Isabelle Desombere

4

object named as

Isabelle Desombere

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

5

object named as

Ali Farhoudi

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Katarzyna Grzyb

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Riccardo Cortese

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Alfredo Nicosia

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

16 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

364-372

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Role of lipid metabolism in hepatitis C virus assembly and entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Early steps of the hepatitis C virus life cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Prevention and treatment of hepatitis C virus recurrence after liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hepatitis C virus replication in mice with chimeric human livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Binding of hepatitis C virus to CD81

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262867

27 July 2018

Hepatitis C virus kinetics during and immediately after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Robust hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Characterization of the cross-neutralizing antibody response against hepatitis C virus in the liver transplantation setting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24692

21 January 2018

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21953761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail

1 reference

https://pubmed.ncbi.nlm.nih.gov/21953761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/HEP.24692

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35685409&oldid=1948935574"